376 related articles for article (PubMed ID: 33657326)
21. CRISPR-Barcoding for Intratumor Genetic Heterogeneity Modeling and Functional Analysis of Oncogenic Driver Mutations.
Guernet A; Mungamuri SK; Cartier D; Sachidanandam R; Jayaprakash A; Adriouch S; Vezain M; Charbonnier F; Rohkin G; Coutant S; Yao S; Ainani H; Alexandre D; Tournier I; Boyer O; Aaronson SA; Anouar Y; Grumolato L
Mol Cell; 2016 Aug; 63(3):526-38. PubMed ID: 27453044
[TBL] [Abstract][Full Text] [Related]
22. Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development.
Dzobo K; Senthebane DA; Thomford NE; Rowe A; Dandara C; Parker MI
OMICS; 2018 Jan; 22(1):17-34. PubMed ID: 29356626
[TBL] [Abstract][Full Text] [Related]
23. Group Behavior and Emergence of Cancer Drug Resistance.
Bhattacharya S; Mohanty A; Achuthan S; Kotnala S; Jolly MK; Kulkarni P; Salgia R
Trends Cancer; 2021 Apr; 7(4):323-334. PubMed ID: 33622644
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression.
Lüönd F; Tiede S; Christofori G
Br J Cancer; 2021 Jul; 125(2):164-175. PubMed ID: 33824479
[TBL] [Abstract][Full Text] [Related]
25. Clonal cooperativity in heterogenous cancers.
Zhou H; Neelakantan D; Ford HL
Semin Cell Dev Biol; 2017 Apr; 64():79-89. PubMed ID: 27582427
[TBL] [Abstract][Full Text] [Related]
26. Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer.
Ravindran Menon D; Hammerlindl H; Torrano J; Schaider H; Fujita M
Theranostics; 2020; 10(14):6261-6277. PubMed ID: 32483452
[TBL] [Abstract][Full Text] [Related]
27. Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance.
Bhat GR; Sethi I; Sadida HQ; Rah B; Mir R; Algehainy N; Albalawi IA; Masoodi T; Subbaraj GK; Jamal F; Singh M; Kumar R; Macha MA; Uddin S; Akil ASA; Haris M; Bhat AA
Cancer Metastasis Rev; 2024 Mar; 43(1):197-228. PubMed ID: 38329598
[TBL] [Abstract][Full Text] [Related]
28. Cellular Plasticity in Cancer.
Yuan S; Norgard RJ; Stanger BZ
Cancer Discov; 2019 Jul; 9(7):837-851. PubMed ID: 30992279
[TBL] [Abstract][Full Text] [Related]
29. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
Kim JY; Gatenby RA
Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
[TBL] [Abstract][Full Text] [Related]
30. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.
McGranahan N; Swanton C
Cell; 2017 Feb; 168(4):613-628. PubMed ID: 28187284
[TBL] [Abstract][Full Text] [Related]
31. The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity.
Davies A; Zoubeidi A; Beltran H; Selth LA
Cancer Discov; 2023 Aug; 13(8):1771-1788. PubMed ID: 37470668
[TBL] [Abstract][Full Text] [Related]
32. The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer.
Janiszewska M; Stein S; Metzger Filho O; Eng J; Kingston NL; Harper NW; Rye IH; Alečković M; Trinh A; Murphy KC; Marangoni E; Cristea S; Oakes B; Winer EP; Krop IE; Russnes HG; Spellman PT; Bucher E; Hu Z; Chin K; Gray JW; Michor F; Polyak K
JCI Insight; 2021 Jun; 6(11):. PubMed ID: 33886505
[TBL] [Abstract][Full Text] [Related]
33. Intratumor heterogeneity in evolutionary models of tumor progression.
Durrett R; Foo J; Leder K; Mayberry J; Michor F
Genetics; 2011 Jun; 188(2):461-77. PubMed ID: 21406679
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic plasticity and epithelial-to-mesenchymal transition in the behaviour and therapeutic response of oral squamous cell carcinoma.
Vig N; Mackenzie IC; Biddle A
J Oral Pathol Med; 2015 Oct; 44(9):649-55. PubMed ID: 25594908
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic regulation of mRNA mediates the phenotypic plasticity of cancer cells during metastasis and therapeutic resistance (Review).
Zhang C; Liang S; Zhang H; Wang R; Qiao H
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38131215
[TBL] [Abstract][Full Text] [Related]
36. Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy.
Lim ZF; Ma PC
J Hematol Oncol; 2019 Dec; 12(1):134. PubMed ID: 31815659
[TBL] [Abstract][Full Text] [Related]
37. MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma.
Mroz EA; Rocco JW
Oral Oncol; 2013 Mar; 49(3):211-5. PubMed ID: 23079694
[TBL] [Abstract][Full Text] [Related]
38. Cancer cells exhibit clonal diversity in phenotypic plasticity.
Mathis RA; Sokol ES; Gupta PB
Open Biol; 2017 Feb; 7(2):. PubMed ID: 28202626
[TBL] [Abstract][Full Text] [Related]
39. Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance.
Das PK; Pillai S; Rakib MA; Khanam JA; Gopalan V; Lam AKY; Islam F
Stem Cell Rev Rep; 2020 Apr; 16(2):397-412. PubMed ID: 31965409
[TBL] [Abstract][Full Text] [Related]
40. Tumor Evolution, Heterogeneity, and Therapy for Our Patients With Advanced Cancer: How Far Have We Come?
El-Deiry WS; Taylor B; Neal JW
Am Soc Clin Oncol Educ Book; 2017; 37():e8-e15. PubMed ID: 28746017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
